Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Curis Inc (CRIS)

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 732,768
  • Shares Outstanding, K 91,596
  • Annual Sales, $ 10,840 K
  • Annual Income, $ -29,910 K
  • 60-Month Beta 2.90
  • Price/Sales 71.01
  • Price/Cash Flow N/A
  • Price/Book 6.91
Trade CRIS with:

Options Overview Details

View History
  • Implied Volatility 93.86%
  • Historical Volatility 48.20%
  • IV Percentile 11%
  • IV Rank 1.21%
  • IV High 897.62% on 10/09/20
  • IV Low 84.03% on 08/23/21
  • Put/Call Vol Ratio 0.15
  • Today's Volume 276
  • Volume Avg (30-Day) 701
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 10,168
  • Open Int (30-Day) 17,256

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -18.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.81 +2.43%
on 08/25/21
9.04 -11.50%
on 08/31/21
+0.09 (+1.14%)
since 08/24/21
3-Month
6.84 +16.96%
on 08/06/21
9.04 -11.50%
on 08/31/21
+0.30 (+3.90%)
since 06/24/21
52-Week
1.02 +684.31%
on 09/30/20
17.40 -54.02%
on 05/12/21
+6.96 (+669.23%)
since 09/24/20

Most Recent Stories

More News
Curis to Present at Upcoming Healthcare Conferences in September

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that , President and Chief Executive...

CRIS : 8.00 (-4.76%)
Curis (CRIS) Reports Q2 Loss, Lags Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of -9.09% and -1.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 8.00 (-4.76%)
Curis: Q2 Earnings Snapshot

LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $10.8 million in its second quarter.

CRIS : 8.00 (-4.76%)
Curis to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 3, 2021

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its...

CRIS : 8.00 (-4.76%)
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on , the independent Compensation...

CRIS : 8.00 (-4.76%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS

Pomerantz LLP is investigating claims on behalf of investors of Curis, Inc. ("Curis" or the "Company") (NASDAQ: CRIS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com...

CRIS : 8.00 (-4.76%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS

New York, New York--(Newsfile Corp. - June 26, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Curis, Inc.("Curis" or the "Company") (NASDAQ: CRIS). Such investors are advised...

CRIS : 8.00 (-4.76%)
Curis, Inc. Set to Join Russell 2000®, 3000® and Microcap® Indexes

/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will be added to the Russell...

CRIS : 8.00 (-4.76%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Curis, Inc. ("Curis" or the "Company") (NASDAQ: CRIS). Such investors are advised to contact at   or 888-476-6529,...

CRIS : 8.00 (-4.76%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Curis, Inc. - CRIS

Pomerantz LLP is investigating claims on behalf of investors of Curis, Inc. ("Curis" or the "Company") (NASDAQ: CRIS). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com...

CRIS : 8.00 (-4.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate...

See More

Key Turning Points

3rd Resistance Point 8.52
2nd Resistance Point 8.42
1st Resistance Point 8.21
Last Price 8.00
1st Support Level 7.89
2nd Support Level 7.79
3rd Support Level 7.58

See More

52-Week High 17.40
Fibonacci 61.8% 11.14
Fibonacci 50% 9.21
Last Price 8.00
Fibonacci 38.2% 7.28
52-Week Low 1.02

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar